BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11034006)

  • 1. Granular cells as a marker of early amiodarone hepatotoxicity.
    Jain D; Bowlus CL; Anderson JM; Robert ME
    J Clin Gastroenterol; 2000 Oct; 31(3):241-3. PubMed ID: 11034006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity.
    Giannattasio F; Salvio A; Varriale M; Picciotto FP; Di Costanzo GG; Visconti M
    Ann Ital Med Int; 2002; 17(3):180-4. PubMed ID: 12402666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early-onset acute toxic hepatitis induced by intravenous amiodarone administration].
    González Galilea A; García Sánchez MV; la Mata García M; Miño Fugarolas G
    Gastroenterol Hepatol; 2002; 25(6):392-4. PubMed ID: 12069701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute liver injury after intravenous amiodarone: a case report.
    Verhovez A; Elia F; Riva A; Ferrari G; Aprà F
    Am J Emerg Med; 2011 Sep; 29(7):843.e5-6. PubMed ID: 20870371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute amiodarone liver toxicity likely due to ischemic hepatitis.
    Gluck N; Fried M; Porat R
    Isr Med Assoc J; 2011 Dec; 13(12):748-52. PubMed ID: 22332445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy.
    James PR; Hardman SM
    Heart; 1997 Jun; 77(6):583-4. PubMed ID: 9227310
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone].
    López-Gómez D; Nicolás J; Frigola JM; Manito N; Esplugas E
    Rev Esp Cardiol; 1999 Mar; 52(3):201-3. PubMed ID: 10193175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the Literature.
    Chen CC; Wu CC
    Am J Ther; 2016; 23(1):e260-3. PubMed ID: 25259952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications and acute hepatotoxicity of intravenous amiodarone.
    Huang X; Yang Y; Zhu J; Gao X; Wang G; Tan H; Liang Y; Li J
    J Int Med Res; 2009; 37(6):1928-36. PubMed ID: 20146893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute hepatotoxicity from intravenous amiodarone in a patient on hemodialysis].
    Bucco S; Arazzi M; Giunta F; Grabocka X; Longo MO; Silvestri S; Spetrino N; Tondo M; Vigilante G; Bonomini M
    G Ital Nefrol; 2016; 33(1):. PubMed ID: 26913742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute hepatitis caused by intravenous amiodarone].
    Paniagua Clusells J; Arcusa Gavalda R; Goma Masip F; Pons Masanes S; Soler Masana JM
    Rev Esp Cardiol; 1996 May; 49(5):384-5. PubMed ID: 8744394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxic hepatitis caused by intravenous amiodarone].
    Luengo O; Montero J; Alegre J; Fernández Sevilla T
    Med Clin (Barc); 2000 Dec; 115(20):798-9. PubMed ID: 11171458
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute hepatitis induced by parenteral amiodarone.
    Gregory SA; Webster JB; Chapman GD
    Am J Med; 2002 Aug; 113(3):254-5. PubMed ID: 12208392
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe hepatotoxicity caused by amiodarone: description of a case].
    Latorre G; Lucas I; Herrero JI; Sangro B; Quiroga J; Sola JJ; Díaz L; Prieto J
    Rev Med Univ Navarra; 1999; 43(2):86-91. PubMed ID: 11256009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose amiodarone-induced fatal liver failure.
    Akbal E; Batgi H; Koçak E; Canatan T; Köklü S
    Drug Chem Toxicol; 2013 Apr; 36(2):261-2. PubMed ID: 22356138
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe acute hepatitis following intravenous amiodarone : a case report and review of the literature.
    Stratton A; Fenderson J; Kenny P; Helman DL
    Acta Gastroenterol Belg; 2015 Jun; 78(2):233-9. PubMed ID: 26151694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone hepatotoxicity.
    Babatin M; Lee SS; Pollak PT
    Curr Vasc Pharmacol; 2008 Jul; 6(3):228-36. PubMed ID: 18673162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone.
    Hashmi A; Keswani NR; Kim S; Graham DY
    South Med J; 2016 Feb; 109(2):83-6. PubMed ID: 26840961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causality assessment of liver injury after chronic oral amiodarone intake.
    Llanos L; Moreu R; Peiró AM; Pascual S; Francés R; Such J; Horga JF; Pérez-Mateo M; Zapater P
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):291-300. PubMed ID: 19165760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure.
    Mattar W; Juliar B; Gradus-Pizlo I; Kwo PY
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):419-23. PubMed ID: 20076813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.